期刊文献+

Novel rat model of multiple mitochondrial dysfunction syndromes(MMDS)complicated with cardiomyopathy 被引量:2

下载PDF
导出
摘要 Background:Multiple mitochondrial dysfunction syndromes(MMDS)presents as complex mitochondrial damage,thus impairing a variety of metabolic pathways.Heart dysplasia has been reported in MMDS patients;however,the specific clinical symptoms and pathogenesis remain unclear.More urgently,there is a lack of an animal model to aid research.Therefore,we selected a reported MMDS causal gene,Isca1,and established an animal model of MMDS complicated with cardiac dysplasia.Methods:The myocardium-specific Isca1 knockout heterozygote(Isca1 HET)rat was obtained by crossing the Isca1 conditional knockout(Isca1 cKO)rat with theαmyosin heavy chain Cre(α-MHC-Cre)rat.Cardiac development characteristics were determined by ECG,blood pressure measurement,echocardiography and histopatho-logical analysis.The responsiveness to pathological stimuli were observed through adriamycin treatment.Mitochondria and metabolism disorder were determined by activity analysis of mitochondrial respiratory chain complex and ATP production in myocardium.Results:ISCA1 expression in myocardium exhibited a semizygous effect.Isca1 HET rats exhibited dilated cardiomyopathy characteristics,including thin-walled ventri-cles,larger chambers,cardiac dysfunction and myocardium fibrosis.Downregulated ISCA1 led to deteriorating cardiac pathological processes at the global and organiza-tional levels.Meanwhile,HET rats exhibited typical MMDS characteristics,including damaged mitochondrial morphology and enzyme activity for mitochondrial respira-tory chain complexesⅠ,ⅡandⅣ,and impaired ATP production.Conclusion:We have established a rat model of MMDS complicated with cardiomyopathy,it can also be used as model of myocardial energy metabolism dysfunction and mitochondrial cardiomyopathy.This model can be applied to the study of the mechanism of energy metabolism in cardiovascular diseases,as well as research and development of drugs.
出处 《Animal Models and Experimental Medicine》 CSCD 2021年第4期381-390,共10页 动物模型与实验医学(英文)
基金 The present work was supported in part by the Beijing Natural Science Foundation(5212017) CAMS Innovation Fund for Medical Sciences(CIFMS,2016-I2M-1-015) National Natural Science Foundation(31872314 and 31970508).
  • 相关文献

参考文献2

二级参考文献16

  • 1Cui X, Ji D, Fisher DA, et al. Nat Biotechnol2011; 29:64-67. 被引量:1
  • 2Brown AJ, Fisher DA, Kouranova E, et al. Nat Methods 2013; 10:638- 640. 被引量:1
  • 3Tesson L, Usal C, Menoret S, et al. Nat Biotechnol 2011; 29:695-696. 被引量:1
  • 4Li W, Teng F, Li T, et al. Nat Biotechnol 2013; 31:684-686. 被引量:1
  • 5Li D, Qiu Z, Shao Y, et al. Nat Biotechnol 2013; 31:681-683. 被引量:1
  • 6Bedell VM, Wang Y, Campbell JM, et al. Nature 2012; 491:114-118. 被引量:1
  • 7Yang H, Wang H, Shivalila CS, et al. Cell 2013; 154:1370-1379. 被引量:1
  • 8Law JA, Jacobsen SE. Nat Rev Genet 2010; 11:204-220. 被引量:1
  • 9Sapranauskas R, Gasiunas G, Fremaux C, et al. Nucleic Acids Res 2011; 39:9275-9282. 被引量:1
  • 10Shen B, Zhang J, Wu H, et al. Cell Res 2013; 23:720-723. 被引量:1

共引文献68

同被引文献24

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部